within Pharmacolibrary.Drugs.ATC.R;

model R02AB30
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.01,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 3 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 0
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R02AB30</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Gramicidin is a mixture of peptide antibiotics produced by Bacillus brevis. It is primarily used topically for the treatment of gram-positive bacterial infections, especially in oropharyngeal conditions (such as sore throat). It is not used systemically because of its toxicity. Gramicidin is still available in some countries as a component of throat lozenges and topical antibiotics.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic parameters found for gramicidin in humans. Systemic pharmacokinetic data is unavailable due to its high toxicity and exclusive topical/oral local use.</p><h4>References</h4><ol><li><p>Smirnov, S, et al., &amp; Demin, O (2009). Optimization of antimicrobial drug gramicidin S dosing regime using biosimulations. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 36(1) 105–109. DOI:<a href=\"https://doi.org/10.1016/j.ejps.2008.10.017\">10.1016/j.ejps.2008.10.017</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/19027851/\">https://pubmed.ncbi.nlm.nih.gov/19027851</a></p></li><li><p>Blanco, MJ (2019). Building upon Nature&#x27;s Framework: Overview of Key Strategies Toward Increasing Drug-Like Properties of Natural Product Cyclopeptides and Macrocycles. <i>Methods in molecular biology (Clifton, N.J.)</i> 2001 203–233. DOI:<a href=\"https://doi.org/10.1007/978-1-4939-9504-2_10\">10.1007/978-1-4939-9504-2_10</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31134573/\">https://pubmed.ncbi.nlm.nih.gov/31134573</a></p></li><li><p>Soltoff, SP, et al., &amp; Talamo, BR (1992). ATP activates a cation-permeable pathway in rat parotid acinar cells. <i>The American journal of physiology</i> 262(4 Pt 1) C934–C940. DOI:<a href=\"https://doi.org/10.1152/ajpcell.1992.262.4.C934\">10.1152/ajpcell.1992.262.4.C934</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1566819/\">https://pubmed.ncbi.nlm.nih.gov/1566819</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R02AB30;
